Additional Studies. If a Party would like to conduct additional clinical studies using the Combination, at the request of such Party, the Parties shall discuss in good faith the possibility of, and the terms and conditions for, conducting such clinical studies, including cost sharing, decision making and the supply of Compounds. This Section shall survive the expiration of this Agreement for a period of ***.
Appears in 3 contracts
Sources: Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc)